2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
36
AVTX Quote, Financials, Valuation and Earnings
Last price:
$3.98
Seasonality move
:
-0.66%
Day range:
$3.61 - $4.00
52-week range:
$3.39 - $16.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
0.35x
Volume:
60.6K
Avg. volume:
59.3K
1-year change:
-65.96%
Market cap:
$43.3M
Revenue:
$441K
EPS (TTM):
-$3,384.24
Earnings Data
Next earnings date for AVTX
Aug 12
2025
Most recent earnings per share
-$1.25
Beat by $0.36
(May 12/2025)
Consensus Estimate
-$1.61
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AVTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/12/2025 | Q2 | -- | -- | -- | -$1.21 | -- |
| 05/12/2025 | Q1 | -- | -- | -$1.25 | -$1.61 | $0.36 |
| 03/20/2025 | Q4 | -- | $192K | -$3.36 | $1.67 | -$5.02 |
| 11/07/2024 | Q3 | -- | $249K | -$2.83 | -- | -- |
| 08/12/2024 | Q2 | -- | -- | -$3,376.80 | -- | -- |
| 05/13/2024 | Q1 | -- | -- | -$141.00 | -- | -- |
| 12/31/2023 | Q4 | $300K | $571K | -$10.19 | -- | -- |
| 11/09/2023 | Q3 | $1M | $236K | -$26.83 | -- | -- |
| 08/03/2023 | Q2 | $500K | $643K | -$140.73 | -$168.00 | $27.27 |
| 05/04/2023 | Q1 | $1M | $475K | -$204.00 | -$232.80 | $28.80 |
| 03/02/2023 | Q4 | $3.6M | $896K | -$249.40 | -$156.00 | -$93.40 |
| 11/07/2022 | Q3 | -- | $14.9M | $81.60 | -- | -- |
| 08/04/2022 | Q2 | -- | $1M | -$331.20 | -- | -- |
| 05/05/2022 | Q1 | -- | $1.2M | -$564.00 | -- | -- |
| 03/02/2022 | Q4 | -- | $219K | -$463.20 | -- | -- |
| 11/09/2021 | Q3 | -- | $1.4M | -$499.20 | -- | -- |
| 08/02/2021 | Q2 | -- | $3.4M | -$506.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $473K | -$921.60 | -- | -- |
| 12/31/2020 | Q4 | -- | $1.5M | -$518.40 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.1M | -$489.60 | -- | -- |
| 06/30/2020 | Q2 | -- | $1.3M | -$547.20 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.8M | -$979.20 | -- | -- |
| 12/31/2019 | Q4 | -- | $580.8K | $86.40 | -- | -- |
| 09/30/2019 | Q3 | -- | $2.2M | -$201.60 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.4M | -$316.80 | -- | -- |
| 03/31/2019 | Q1 | -- | $2.6M | -$374.40 | -- | -- |
| 12/31/2018 | Q4 | -- | -$6.3M | -$432.00 | -- | -- |
| 09/30/2018 | Q3 | -- | $4.1M | -$2,044.80 | -- | -- |
| 06/30/2018 | Q2 | -- | $4.8M | -$547.20 | -- | -- |
| 03/31/2018 | Q1 | -- | $4.5M | -$345.60 | -- | -- |
| 12/31/2017 | Q4 | -- | $2.2M | -$662.40 | -- | -- |
| 09/30/2017 | Q3 | -- | $25M | $1,497.60 | -- | -- |
| 06/30/2017 | Q2 | -- | $157.8K | -$403.20 | -- | -- |
| 03/31/2017 | Q1 | -- | $384.2K | -$547.20 | -- | -- |
| 12/31/2016 | Q4 | -- | $181K | -$518.40 | -- | -- |
| 09/30/2016 | Q3 | -- | $321.5K | -$2,016.00 | -- | -- |
| 06/30/2016 | Q2 | -- | $650.5K | -$1,180.80 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,699.20 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1,526.40 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$230.67 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$1,812.54 | -- | -- |
Avalo Therapeutics Earnings Questions
-
How Much did Avalo Therapeutics Generate in Revenue Last Quarter?
Avalo Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Avalo Therapeutics Beat Earnings Last Quarter?
Avalo Therapeutics announced earnings per share of -$1.25 which represents a beat of analyst forecast a -$1.61 per share.
-
Is Avalo Therapeutics Profitable?
Avalo Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Avalo Therapeutics EPS Next Year?
Avalo Therapeutics's earnings are forecast to decrease from -$20.91 per share to $12.92 per share next year representing a decrease of -79.13%.
-
When is Avalo Therapeutics's Earnings Date?
Avalo Therapeutics's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
